Methionine sulfoxide at Aβ and numerous tau protein phosphorylation sites in the insoluble proteins characteristic for Alzheimer’s disease were identified, while no post-translational modifications were enriched with ApoE or GFAP (Boutte et al. 2006). The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.